| |
1 |
2 |
3 |
4 |
5 |
| Q1*. Trachoma is the 3rd major cause of preventable infectious blindness worldwide. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q2. Trachoma is considered a neglected tropical disease. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q3. Measures such as surgery (if necessary) antibiotics using, facial cleansing and environmental care are recommended to combat trachoma. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q4. Trachoma is usually associated with poor basic sanitation, hygiene and education. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q5. Estimates show 21 million people with active trachoma, of whom 2 million are blind or have severe visual impairment due to it. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q6. Active trachoma prevalence decreases with age. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q7. High prevalence of trachomatous trichiasis, scarring and corneal opacity in elderly is associated with early exposure to trachoma. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q8. The 50s-70s economic development period in Brazil encouraged significant decrease in trachoma, which created the "trachoma eradication misconception". |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q9*. Studies have shown that trachoma occurs in few Brazilian regions. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q10. Trachoma is caused by the bacterium Chlamydia trachomatis. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q11*. Trichiasis is featured by the presence of inverted cilia irritating the cornea. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q12. Chlamydia trachomatis, mostly associated with genital infection, can also cause ophthalmia neonatorum in infants and inclusion conjunctivitis in adults. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q13. Trachomatous scarring has been associated with the presence of pathogens other than Chlamydia trachomatis. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q14. Trachomatous Inflammation - Follicular (TF) is featured by five or more follicles of at least 0.5 mm in diameter in the upper palpebral conjunctiva |
DELETED |
| Q15. Trachomatous Inflammation - Intense (TI) occurs when conjunctival thickening in the upper eyelid obscures more than 50% of the normal deep tarsal vessels. |
DELETED |
| Q16. Trachomatous Scarring (TS) is featured by apparent scars in the upper palpebral conjunctiva. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q17. Trachomatous trichiasis (TT) is featured by one or more eyelashes rubbing against the eyeball, or by scarring after upper eyelid surgery. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q18. Trachomatous Corneal Opacification (CO) in case of corneal opacity covering the pupillary margin. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q19*. Entropion is a condition in which the eyelid margin turns inward and causes eyelashes to move away from the cornea. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q20*. The World Health Organization created the trachoma grading system so that experts can quickly assess trachoma prevalence and severity within populations. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q21*. Chlamydia trachomatis may cause chronic conjunctivitis followed by intense symptoms, such as severe pruritus, hyperemia and eye discharge. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q22. Trachoma is often mistaken for allergic conjunctivitis, since both can coexist in the same patient. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q23*. Trachoma diagnosis is primarily clinical. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q24. WHO advises that trachoma should be diagnosed if at least two of the following symptoms are detected: follicles on upper tarsal conjunctiva, limbal follicles, typical conjunctival scarring and superior limbal pannus. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q25. The active trachoma types are: Trachomatous Inflammation - Follicular (TF) and Trachomatous Inflammation - Intense (TI). |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q26. The scarring or sequelae types of trachoma are Trachomatous Trichiasis (TT) and Corneal Opacification (CO). |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q27. Trachomatous scarring requires surgical intervention. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q28. Although trachoma prevalence in Brazil has been evidenced, this disease is not regularly discussed at medical schools and specialization courses. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q29. Trichiasis and entropion tend to recur after surgical treatment. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q30*. The treatment of choice for active trachoma is single-dose, orally administered ciprofloxacin. |
DELETED |
| Q31. Erythromycin and doxycycline feature among trachoma systemic treatment alternatives. |
DELETED |
| Q32*. Ciprofloxacin eye drops, tetracycline ointment and sulfa eye drops are modern treatment alternatives. |
DELETED |
| Q33*. Mass treatment is recommended when trachoma prevalence rate is higher than 50%. |
DELETED |
| Q34*. Trachoma has not yet been eradicated in most developed countries even after improved access to water, sanitation and housing. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q35. Conjunctival folliculosis, toxic follicular conjunctivitis, inclusion conjunctivitis and acute follicular conjunctivitis should receive differential trachoma diagnosis. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q36*. Children younger than 3 years old are the main reservoir of trachoma's infectious agent in endemic trachoma areas. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q37. Trachoma can only be transmitted when there are active lesions, which are more severe at the beginning of the disease and when they are caused by bacterial infections. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q38*. A single case of infectious conjunctivitis caused by etiologic agents is enough to determine clinical trachoma. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q39*. Active trachoma patients should be discharged one year after treatment had started, when trachoma symptoms are no longer observed. |
DELETED |
| Q40. Suspected trachoma cases are considered serious when patients have history of recurrent conjunctivitis or persistent eye symptoms, such as: burning, itching, foreign body sensation, photophobia, excessive tearing and eye discharge. |
☐ |
☐ |
☐ |
☐ |
☐ |
| Q41*. Health education is unnecessary for trachoma prevention and control. |
☐ |
☐ |
☐ |
☐ |
☐ |
| (*) False statements. |
